Bio-Rad Reports Q2 2025 Earnings Results
Bio-Rad (BIO) reported Q2 2025 earnings with revenue of $652 million, up 2.1% reported and 1% currency-neutral, driven by process chromatography sales. However, gross margin declined to 53% reported and 53.7% non-GAAP, down from 55.6% and 56.4% respectively, due to higher material costs and lower instrument demand.
Topics: earnings gross margin operating income revenue sales segment performance